UBS 'rogue' trader pleads not guilty to charges

clock

The alleged rogue trader at the heart of a multi-billion pound fraud investigation has pleaded not guilty to two charges of false accounting and two of fraud.

Kweku Adoboli, who worked for Swiss bank UBS, appeared at Southwark Crown Court accused of unauthorised trading that lost the bank around £1.5bn ($2.3bn). Adoboli, the 31-year-old who worked for UBS's global synthetic equities division, was remanded in custody by the Judge Alistair McCreath after his plea. He was arrested back in September when the scandal broke. In the wake of the losses, a number of high profile figures at UBS quit the firm, including Oswald Gruebel, the chief executive, and the chief risk officer. A provisional trial date of 3 September has been set.

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Economics

Tariffs drive record fall in UK exports to US

Tariffs drive record fall in UK exports to US

Imports fall by £400m

Linus Uhlig
clock 12 June 2025 • 2 min read
Partner Insight: What are the implications of policies of the Trump Administration on EMD?

Partner Insight: What are the implications of policies of the Trump Administration on EMD?

Matthew Murphy, Institutional Portfolio Manager of the Emerging Markets Team at Morgan Stanley Investment Management (MSIM), shared his view on the implications of the policies introduced by the Trump Administration for emerging market debt (EMD). Murphy then explained the firm’s approach to the EMD segment.

Matthew Murphy, Institutional Portfolio Manager of the Emerging Markets Team at Morgan Stanley Investment Management (MSIM)
clock 12 June 2025 • 7 min read
US-China trade talks progress pending framework approval from Trump and Xi

US-China trade talks progress pending framework approval from Trump and Xi

Following London meetings

Linus Uhlig
clock 11 June 2025 • 1 min read
Trustpilot